These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32284151)

  • 1. Recommendations of statin treatment after acute coronary syndrome: Hungarian experiences.
    Mark L; Janosi A; Ferenci T; Toth PP
    Atherosclerosis; 2020 Jun; 303():53-54. PubMed ID: 32284151
    [No Abstract]   [Full Text] [Related]  

  • 2. Treat-to-target lipid control is effective but highlighted poor prognosis without indication of statin following percutaneous coronary intervention.
    Tanaka S; Ikari Y; Ijichi T; Nakazawa G
    Cardiovasc Interv Ther; 2017 Oct; 32(4):358-364. PubMed ID: 27539447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of high-dose statin pre-treatment and contrast-induced acute kidney injury on follow-up events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Patti G; Leoncini M; Toso A; Maioli M; Grieco D; Colonna G; Bellandi F; Di Sciascio G
    Int J Cardiol; 2014 Jun; 174(2):440-1. PubMed ID: 24767765
    [No Abstract]   [Full Text] [Related]  

  • 4. Should We Up the Intensity of Statin Therapy After Placing a Drug-eluting Stent?
    Parikh KH; Kirtane AJ
    Rev Esp Cardiol (Engl Ed); 2018 Jun; 71(6):416-417. PubMed ID: 29104001
    [No Abstract]   [Full Text] [Related]  

  • 5. High-Intensity Statins Before Percutaneous Coronary Intervention in Acute Coronary Syndrome-Should It Be Added to Treatment Algorithm?
    Cutlip DE
    Am J Cardiol; 2023 Jun; 196():104-105. PubMed ID: 37059611
    [No Abstract]   [Full Text] [Related]  

  • 6. Statins and Incidence of Contrast-Induced Acute Kidney Injury Following Coronary Angiography - Five Year Experience at a Tertiary Care Center.
    Sreenivasan J; Khan MS; Li H; Zhuo M; Patel A; Fugar S; Tarbutton M; Siddamsetti S; Yadav N
    Cardiovasc Revasc Med; 2019 Aug; 20(8):654-658. PubMed ID: 30318173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Navarese EP; Kowalewski M; Andreotti F; van Wely M; Camaro C; Kolodziejczak M; Gorny B; Wirianta J; Kubica J; Kelm M; de Boer MJ; Suryapranata H
    Am J Cardiol; 2014 May; 113(10):1753-64. PubMed ID: 24792742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 4 Statins on Regression of Coronary Plaque in Acute Coronary Syndrome.
    Matsushita K; Hibi K; Komura N; Akiyama E; Maejima N; Iwahashi N; Tsukahara K; Kosuge M; Ebina T; Sumita S; Umemura S; Kimura K
    Circ J; 2016 Jun; 80(7):1634-43. PubMed ID: 27264413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prompt impact of first prospective statin mega-trials on postoperative lipid management of CABG patients: a 20-year follow-up in a single hospital.
    Palomäki A; Hällberg V; Ala-Korpela M; Kovanen PT; Malminiemi K
    Lipids Health Dis; 2016 Jul; 15(1):124. PubMed ID: 27460359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: assessment by optical coherence tomography study.
    Takarada S; Imanishi T; Kubo T; Tanimoto T; Kitabata H; Nakamura N; Tanaka A; Mizukoshi M; Akasaka T
    Atherosclerosis; 2009 Feb; 202(2):491-7. PubMed ID: 18572175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial.
    Nicholls SJ; Andrews J; Kastelein JJP; Merkely B; Nissen SE; Ray KK; Schwartz GG; Worthley SG; Keyserling C; Dasseux JL; Griffith L; Kim SW; Janssan A; Di Giovanni G; Pisaniello AD; Scherer DJ; Psaltis PJ; Butters J
    JAMA Cardiol; 2018 Sep; 3(9):815-822. PubMed ID: 30046828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Lipoprotein (a) on Long-Term Outcomes in Patients with Coronary Artery Disease Treated with Statin After a First Percutaneous Coronary Intervention.
    Suwa S; Ogita M; Miyauchi K; Sonoda T; Konishi H; Tsuboi S; Wada H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Daida H
    J Atheroscler Thromb; 2017 Nov; 24(11):1125-1131. PubMed ID: 28321012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipid-lowering therapy of patients suffering from acute coronary syndrome in a Hungarian county hospital in 2015].
    Márk L; Nagy M; Dani G; Baranyai C; Borbély M; Katona A; Jambrik Z
    Orv Hetil; 2018 Mar; 159(12):478-484. PubMed ID: 29552926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Low-Dose Statin Versus Low-Dose Statin + Armolipid Plus in High-Intensity Statin-Intolerant Patients With a Previous Coronary Event and Percutaneous Coronary Intervention (ADHERENCE Trial).
    Marazzi G; Campolongo G; Pelliccia F; Quattrino S; Vitale C; Cacciotti L; Massaro R; Volterrani M; Rosano G
    Am J Cardiol; 2017 Sep; 120(6):893-897. PubMed ID: 28781026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the efficacy of statin treatment in acute coronary syndromes.
    Rosa GM; Carbone F; Parodi A; Massimelli EA; Brunelli C; Mach F; Vuilleumier N; Montecucco F
    Eur J Clin Invest; 2014 May; 44(5):501-15. PubMed ID: 24601937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal Trends of High-Intensity Statin Therapy Among Veterans Treated With Percutaneous Coronary Intervention.
    Bin Abdulhak AA; Vaughan-Sarrzin M; Kaboli P; Horwitz PA; Mosher H; Sigurdsson G; Walker NE; Wallace R; Robinson JG
    J Am Heart Assoc; 2018 Mar; 7(5):. PubMed ID: 29503265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
    Guedeney P; Claessen BE; Baber U; Camaj A; Sorrentino S; Aquino M; Blum M; Chandiramani R; Goel R; Elsayed S; Kovacic JC; Sweeny J; Barman N; Moreno P; Dangas GD; Kini A; Sharma S; Mehran R
    Am J Cardiol; 2019 Jun; 123(11):1788-1795. PubMed ID: 30955866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary prevention after acute coronary syndrome.
    Murín J; Bulas J; Gašpar U; Klabník A; Wawruch M
    Vnitr Lek; 2020; 66(4):236-241. PubMed ID: 32972181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of statin therapy on platelet reactivity after percutaneous coronary revascularization in patients with acute coronary syndrome.
    Toso A; De Servi S; Leoncini M; Angiolillo DJ; Calabrò P; Piscione F; Cattaneo M; Maffeo D; Bartorelli A; Palmieri C; De Carlo M; Capodanno D; Genereux P; Bellandi F; Barozzi C; Tomasi L; Della Riva D; Palmerini T
    J Thromb Thrombolysis; 2017 Oct; 44(3):355-361. PubMed ID: 28840456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of nonfasting triglycerides/high-density lipoprotein cholesterol ratio on secondary prevention in patients treated with statins.
    Matsumoto I; Misaki A; Kurozumi M; Nanba T; Takagi Y
    J Cardiol; 2018 Jan; 71(1):10-15. PubMed ID: 28916255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.